Department Stores
Compare Stocks
4 / 10Stock Comparison
DDS vs BKE vs ANF vs CATO
Revenue, margins, valuation, and 5-year total return — side by side.
Apparel - Retail
Apparel - Retail
Apparel - Retail
DDS vs BKE vs ANF vs CATO — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Department Stores | Apparel - Retail | Apparel - Retail | Apparel - Retail |
| Market Cap | $6.60B | $2.66B | $3.60B | $53M |
| Revenue (TTM) | $6.56B | $1.28B | $5.27B | $660M |
| Net Income (TTM) | $571M | $206M | $507M | $-10M |
| Gross Margin | 38.3% | 48.9% | 58.6% | 32.2% |
| Operating Margin | 10.5% | 20.1% | 13.4% | -2.4% |
| Forward P/E | 16.3x | 12.9x | 8.0x | — |
| Total Debt | $358M | $326M | $1.17B | $146M |
| Cash & Equiv. | $862M | $267M | $760M | $20M |
DDS vs BKE vs ANF vs CATO — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Dillard's, Inc. (DDS) | 100 | 1844.3 | +1744.3% |
| The Buckle, Inc. (BKE) | 100 | 371.9 | +271.9% |
| Abercrombie & Fitch… (ANF) | 100 | 675.6 | +575.6% |
| The Cato Corporation (CATO) | 100 | 30.1 | -69.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: DDS vs BKE vs ANF vs CATO
Each card shows where this stock fits in a portfolio — not just who wins on paper.
DDS has the current edge in this matchup, primarily because of its strength in long-term compounding and sleep-well-at-night.
- 8.7% 10Y total return vs BKE's 225.7%
- Lower volatility, beta 1.15, Low D/E 15.2%, current ratio 2.65x
- 5.6% yield, 12-year raise streak, vs CATO's 18.7%, (1 stock pays no dividend)
- +65.5% vs ANF's +12.7%
BKE is the #2 pick in this set and the best alternative if quality and efficiency is your priority.
- 16.1% margin vs CATO's -1.5%
- 20.6% ROA vs CATO's -2.2%, ROIC 38.4% vs -6.7%
ANF is the clearest fit if your priority is growth exposure.
- Rev growth 6.4%, EPS growth -2.2%, 3Y rev CAGR 12.5%
- 6.4% revenue growth vs CATO's -8.2%
- Better valuation composite
CATO is the clearest fit if your priority is income & stability and defensive.
- Dividend streak 0 yrs, beta 0.88, yield 18.7%
- Beta 0.88, yield 18.7%, current ratio 1.19x
- Beta 0.88 vs ANF's 1.42
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 6.4% revenue growth vs CATO's -8.2% | |
| Value | Better valuation composite | |
| Quality / Margins | 16.1% margin vs CATO's -1.5% | |
| Stability / Safety | Beta 0.88 vs ANF's 1.42 | |
| Dividends | 5.6% yield, 12-year raise streak, vs CATO's 18.7%, (1 stock pays no dividend) | |
| Momentum (1Y) | +65.5% vs ANF's +12.7% | |
| Efficiency (ROA) | 20.6% ROA vs CATO's -2.2%, ROIC 38.4% vs -6.7% |
DDS vs BKE vs ANF vs CATO — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
DDS vs BKE vs ANF vs CATO — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
BKE leads in 2 of 6 categories
DDS leads 1 • ANF leads 0 • CATO leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
BKE leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
DDS is the larger business by revenue, generating $6.6B annually — 9.9x CATO's $660M. BKE is the more profitable business, keeping 16.1% of every revenue dollar as net income compared to CATO's -1.5%. On growth, BKE holds the edge at +9.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $6.6B | $1.3B | $5.3B | $660M |
| EBITDAEarnings before interest/tax | $868M | $282M | $862M | -$5M |
| Net IncomeAfter-tax profit | $571M | $206M | $507M | -$10M |
| Free Cash FlowCash after capex | $620M | $215M | $378M | -$7M |
| Gross MarginGross profit ÷ Revenue | +38.3% | +48.9% | +58.6% | +32.2% |
| Operating MarginEBIT ÷ Revenue | +10.5% | +20.1% | +13.4% | -2.4% |
| Net MarginNet income ÷ Revenue | +8.7% | +16.1% | +9.6% | -1.5% |
| FCF MarginFCF ÷ Revenue | +9.5% | +16.8% | +7.2% | -1.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | -3.0% | +9.3% | +5.4% | +6.3% |
| EPS Growth (YoY)Latest quarter vs prior year | -3.1% | +9.1% | +3.1% | +64.6% |
Valuation Metrics
Evenly matched — ANF and CATO each lead in 3 of 6 comparable metrics.
Valuation Metrics
At 7.5x trailing earnings, ANF trades at a 51% valuation discount to DDS's 15.2x P/E. On an enterprise value basis, ANF's 4.7x EV/EBITDA is more attractive than BKE's 10.3x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $6.6B | $2.7B | $3.6B | $53M |
| Enterprise ValueMkt cap + debt − cash | $6.1B | $2.7B | $4.0B | $178M |
| Trailing P/EPrice ÷ TTM EPS | 15.19x | 13.46x | 7.51x | -3.01x |
| Forward P/EPrice ÷ next-FY EPS est. | 16.32x | 12.87x | 7.98x | — |
| PEG RatioP/E ÷ EPS growth rate | — | 1.06x | — | — |
| EV / EBITDAEnterprise value multiple | 7.02x | 10.31x | 4.68x | — |
| Price / SalesMarket cap ÷ Revenue | 1.01x | 2.18x | 0.68x | 0.08x |
| Price / BookPrice ÷ Book value/share | 3.67x | 6.22x | 2.68x | 0.35x |
| Price / FCFMarket cap ÷ FCF | 10.58x | 13.31x | 9.52x | — |
Profitability & Efficiency
BKE leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
BKE delivers a 44.4% return on equity — every $100 of shareholder capital generates $44 in annual profit, vs $-6 for CATO. DDS carries lower financial leverage with a 0.15x debt-to-equity ratio, signaling a more conservative balance sheet compared to CATO's 0.90x. On the Piotroski fundamental quality scale (0–9), DDS scores 6/9 vs CATO's 2/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +24.3% | +44.4% | +38.5% | -5.8% |
| ROA (TTM)Return on assets | +16.3% | +20.6% | +15.1% | -2.2% |
| ROICReturn on invested capital | +29.7% | +38.4% | +31.4% | -6.7% |
| ROCEReturn on capital employed | +26.0% | +35.3% | +30.5% | -9.6% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 4 | 5 | 2 |
| Debt / EquityFinancial leverage | 0.15x | 0.77x | 0.82x | 0.90x |
| Net DebtTotal debt minus cash | -$504M | $59M | $409M | $126M |
| Cash & Equiv.Liquid assets | $862M | $267M | $760M | $20M |
| Total DebtShort + long-term debt | $358M | $326M | $1.2B | $146M |
| Interest CoverageEBIT ÷ Interest expense | — | — | 302.38x | -1.77x |
Total Returns (Dividends Reinvested)
DDS leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in DDS five years ago would be worth $62,422 today (with dividends reinvested), compared to $3,961 for CATO. Over the past 12 months, DDS leads with a +65.5% total return vs ANF's +12.7%. The 3-year compound annual growth rate (CAGR) favors ANF at 49.9% vs CATO's -21.9% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -13.1% | +4.1% | -36.6% | -2.7% |
| 1-Year ReturnPast 12 months | +65.5% | +57.4% | +12.7% | +27.5% |
| 3-Year ReturnCumulative with dividends | +117.3% | +93.6% | +237.1% | -52.4% |
| 5-Year ReturnCumulative with dividends | +524.2% | +63.6% | +92.7% | -60.4% |
| 10-Year ReturnCumulative with dividends | +872.1% | +225.7% | +219.7% | -72.3% |
| CAGR (3Y)Annualised 3-year return | +29.5% | +24.6% | +49.9% | -21.9% |
Risk & Volatility
Evenly matched — BKE and CATO each lead in 1 of 2 comparable metrics.
Risk & Volatility
CATO is the less volatile stock with a 0.88 beta — it tends to amplify market swings less than ANF's 1.42 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BKE currently trades 84.9% from its 52-week high vs ANF's 59.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.15x | 0.89x | 1.42x | 0.88x |
| 52-Week HighHighest price in past year | $741.98 | $61.69 | $133.11 | $4.92 |
| 52-Week LowLowest price in past year | $348.08 | $35.60 | $65.45 | $2.26 |
| % of 52W HighCurrent price vs 52-week peak | +74.6% | +84.9% | +59.0% | +59.3% |
| RSI (14)Momentum oscillator 0–100 | 44.9 | 52.5 | 33.0 | 48.6 |
| Avg Volume (50D)Average daily shares traded | 99K | 395K | 1.2M | 60K |
Analyst Outlook
Evenly matched — DDS and CATO each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: DDS as "Hold", BKE as "Hold", ANF as "Hold". Consensus price targets imply 53.9% upside for ANF (target: $121) vs 0.3% for DDS (target: $555). For income investors, CATO offers the higher dividend yield at 18.71% vs DDS's 5.62%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold | Hold | — |
| Price TargetConsensus 12-month target | $555.00 | $53.00 | $120.80 | — |
| # AnalystsCovering analysts | 13 | 20 | 55 | — |
| Dividend YieldAnnual dividend ÷ price | +5.6% | +7.5% | — | +18.7% |
| Dividend StreakConsecutive years of raises | 12 | 0 | 0 | 0 |
| Dividend / ShareAnnual DPS | $31.08 | $3.94 | — | $0.55 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +12.5% | +7.4% |
BKE leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). DDS leads in 1 (Total Returns). 3 tied.
DDS vs BKE vs ANF vs CATO: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is DDS or BKE or ANF or CATO a better buy right now?
For growth investors, Abercrombie & Fitch Co.
(ANF) is the stronger pick with 6. 4% revenue growth year-over-year, versus -8. 2% for The Cato Corporation (CATO). Abercrombie & Fitch Co. (ANF) offers the better valuation at 7. 5x trailing P/E (8. 0x forward), making it the more compelling value choice. Analysts rate Dillard's, Inc. (DDS) a "Hold" — based on 13 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — DDS or BKE or ANF or CATO?
On trailing P/E, Abercrombie & Fitch Co.
(ANF) is the cheapest at 7. 5x versus Dillard's, Inc. at 15. 2x. On forward P/E, Abercrombie & Fitch Co. is actually cheaper at 8. 0x.
03Which is the better long-term investment — DDS or BKE or ANF or CATO?
Over the past 5 years, Dillard's, Inc.
(DDS) delivered a total return of +524. 2%, compared to -60. 4% for The Cato Corporation (CATO). Over 10 years, the gap is even starker: DDS returned +872. 1% versus CATO's -72. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — DDS or BKE or ANF or CATO?
By beta (market sensitivity over 5 years), The Cato Corporation (CATO) is the lower-risk stock at 0.
88β versus Abercrombie & Fitch Co. 's 1. 42β — meaning ANF is approximately 61% more volatile than CATO relative to the S&P 500. On balance sheet safety, Dillard's, Inc. (DDS) carries a lower debt/equity ratio of 15% versus 90% for The Cato Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — DDS or BKE or ANF or CATO?
By revenue growth (latest reported year), Abercrombie & Fitch Co.
(ANF) is pulling ahead at 6. 4% versus -8. 2% for The Cato Corporation (CATO). On earnings-per-share growth, the picture is similar: The Cato Corporation grew EPS 17. 1% year-over-year, compared to -11. 6% for The Buckle, Inc.. Over a 3-year CAGR, ANF leads at 12. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — DDS or BKE or ANF or CATO?
The Buckle, Inc.
(BKE) is the more profitable company, earning 16. 1% net margin versus -2. 9% for The Cato Corporation — meaning it keeps 16. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BKE leads at 19. 8% versus -4. 2% for CATO. At the gross margin level — before operating expenses — ANF leads at 58. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is DDS or BKE or ANF or CATO more undervalued right now?
On forward earnings alone, Abercrombie & Fitch Co.
(ANF) trades at 8. 0x forward P/E versus 16. 3x for Dillard's, Inc. — 8. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ANF: 53. 9% to $120. 80.
08Which pays a better dividend — DDS or BKE or ANF or CATO?
In this comparison, CATO (18.
7% yield), BKE (7. 5% yield), DDS (5. 6% yield) pay a dividend. ANF does not pay a meaningful dividend and should not be held primarily for income.
09Is DDS or BKE or ANF or CATO better for a retirement portfolio?
For long-horizon retirement investors, Dillard's, Inc.
(DDS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 15), 5. 6% yield, +872. 1% 10Y return). Both have compounded well over 10 years (DDS: +872. 1%, ANF: +219. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between DDS and BKE and ANF and CATO?
Both stocks operate in the Consumer Cyclical sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: DDS is a small-cap deep-value stock; BKE is a small-cap deep-value stock; ANF is a small-cap deep-value stock; CATO is a small-cap income-oriented stock. DDS, BKE, CATO pay a dividend while ANF does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.